Global Veterinary Therapeutics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 15-Jul-2021
No. of pages: 106
Inquire Before Buying

Market Analysis and Insights: Global Veterinary Therapeutics Market

The global Veterinary Therapeutics market size is projected to reach US$ 40240 million by 2027, from US$ 30060 million in 2020, at a CAGR of 3.8% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Veterinary Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Veterinary Therapeutics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Veterinary Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Veterinary Therapeutics market.

Global Veterinary Therapeutics Scope and Market Size

Veterinary Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Anti-inflammatory

- Parasiticides

- Others

Segment by Application

- Hospitals

- Veterinary Clinics

- Drug Stores

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Bayer AG

- Boehringer Ingelheim GmbH

- Ceva Sante Animale

- Dechra Pharmaceuticals PLC

- Eli Lilly and Company (Elanco Animal Health)

- Merck Animal Health

- Sanofi (Merial Animal Health)

- Virbac

- Vetoquinol S.A.

- Zoetis, Inc.

Global Veterinary Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-inflammatory
1.2.3 Parasiticides
1.2.4 Others
1.3 Market by Application
1.3.1 Global Veterinary Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Veterinary Clinics
1.3.4 Drug Stores
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Therapeutics Market Perspective (2016-2027)
2.2 Veterinary Therapeutics Growth Trends by Regions
2.2.1 Veterinary Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Veterinary Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Veterinary Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Veterinary Therapeutics Industry Dynamic
2.3.1 Veterinary Therapeutics Market Trends
2.3.2 Veterinary Therapeutics Market Drivers
2.3.3 Veterinary Therapeutics Market Challenges
2.3.4 Veterinary Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Therapeutics Players by Revenue
3.1.1 Global Top Veterinary Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Veterinary Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Veterinary Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Veterinary Therapeutics Revenue
3.4 Global Veterinary Therapeutics Market Concentration Ratio
3.4.1 Global Veterinary Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Therapeutics Revenue in 2020
3.5 Veterinary Therapeutics Key Players Head office and Area Served
3.6 Key Players Veterinary Therapeutics Product Solution and Service
3.7 Date of Enter into Veterinary Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Therapeutics Breakdown Data by Type
4.1 Global Veterinary Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Veterinary Therapeutics Forecasted Market Size by Type (2022-2027)
5 Veterinary Therapeutics Breakdown Data by Application
5.1 Global Veterinary Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Veterinary Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Veterinary Therapeutics Market Size (2016-2027)
6.2 North America Veterinary Therapeutics Market Size by Type
6.2.1 North America Veterinary Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Veterinary Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Veterinary Therapeutics Market Size by Type (2016-2027)
6.3 North America Veterinary Therapeutics Market Size by Application
6.3.1 North America Veterinary Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Veterinary Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Veterinary Therapeutics Market Size by Application (2016-2027)
6.4 North America Veterinary Therapeutics Market Size by Country
6.4.1 North America Veterinary Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Veterinary Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Veterinary Therapeutics Market Size (2016-2027)
7.2 Europe Veterinary Therapeutics Market Size by Type
7.2.1 Europe Veterinary Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Veterinary Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Veterinary Therapeutics Market Size by Type (2016-2027)
7.3 Europe Veterinary Therapeutics Market Size by Application
7.3.1 Europe Veterinary Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Veterinary Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Veterinary Therapeutics Market Size by Application (2016-2027)
7.4 Europe Veterinary Therapeutics Market Size by Country
7.4.1 Europe Veterinary Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Veterinary Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Veterinary Therapeutics Market Size by Type
8.2.1 Asia-Pacific Veterinary Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Veterinary Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Veterinary Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Veterinary Therapeutics Market Size by Application
8.3.1 Asia-Pacific Veterinary Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Veterinary Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Veterinary Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Veterinary Therapeutics Market Size by Region
8.4.1 Asia-Pacific Veterinary Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Veterinary Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Veterinary Therapeutics Market Size (2016-2027)
9.2 Latin America Veterinary Therapeutics Market Size by Type
9.2.1 Latin America Veterinary Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Veterinary Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Veterinary Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Veterinary Therapeutics Market Size by Application
9.3.1 Latin America Veterinary Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Veterinary Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Veterinary Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Veterinary Therapeutics Market Size by Country
9.4.1 Latin America Veterinary Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Veterinary Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Veterinary Therapeutics Market Size by Type
10.2.1 Middle East & Africa Veterinary Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Veterinary Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Veterinary Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Veterinary Therapeutics Market Size by Application
10.3.1 Middle East & Africa Veterinary Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Veterinary Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Veterinary Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Veterinary Therapeutics Market Size by Country
10.4.1 Middle East & Africa Veterinary Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Veterinary Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Veterinary Therapeutics Introduction
11.1.4 Bayer AG Revenue in Veterinary Therapeutics Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Boehringer Ingelheim GmbH
11.2.1 Boehringer Ingelheim GmbH Company Details
11.2.2 Boehringer Ingelheim GmbH Business Overview
11.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Introduction
11.2.4 Boehringer Ingelheim GmbH Revenue in Veterinary Therapeutics Business (2016-2021)
11.2.5 Boehringer Ingelheim GmbH Recent Development
11.3 Ceva Sante Animale
11.3.1 Ceva Sante Animale Company Details
11.3.2 Ceva Sante Animale Business Overview
11.3.3 Ceva Sante Animale Veterinary Therapeutics Introduction
11.3.4 Ceva Sante Animale Revenue in Veterinary Therapeutics Business (2016-2021)
11.3.5 Ceva Sante Animale Recent Development
11.4 Dechra Pharmaceuticals PLC
11.4.1 Dechra Pharmaceuticals PLC Company Details
11.4.2 Dechra Pharmaceuticals PLC Business Overview
11.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Introduction
11.4.4 Dechra Pharmaceuticals PLC Revenue in Veterinary Therapeutics Business (2016-2021)
11.4.5 Dechra Pharmaceuticals PLC Recent Development
11.5 Eli Lilly and Company (Elanco Animal Health)
11.5.1 Eli Lilly and Company (Elanco Animal Health) Company Details
11.5.2 Eli Lilly and Company (Elanco Animal Health) Business Overview
11.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Introduction
11.5.4 Eli Lilly and Company (Elanco Animal Health) Revenue in Veterinary Therapeutics Business (2016-2021)
11.5.5 Eli Lilly and Company (Elanco Animal Health) Recent Development
11.6 Merck Animal Health
11.6.1 Merck Animal Health Company Details
11.6.2 Merck Animal Health Business Overview
11.6.3 Merck Animal Health Veterinary Therapeutics Introduction
11.6.4 Merck Animal Health Revenue in Veterinary Therapeutics Business (2016-2021)
11.6.5 Merck Animal Health Recent Development
11.7 Sanofi (Merial Animal Health)
11.7.1 Sanofi (Merial Animal Health) Company Details
11.7.2 Sanofi (Merial Animal Health) Business Overview
11.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Introduction
11.7.4 Sanofi (Merial Animal Health) Revenue in Veterinary Therapeutics Business (2016-2021)
11.7.5 Sanofi (Merial Animal Health) Recent Development
11.8 Virbac
11.8.1 Virbac Company Details
11.8.2 Virbac Business Overview
11.8.3 Virbac Veterinary Therapeutics Introduction
11.8.4 Virbac Revenue in Veterinary Therapeutics Business (2016-2021)
11.8.5 Virbac Recent Development
11.9 Vetoquinol S.A.
11.9.1 Vetoquinol S.A. Company Details
11.9.2 Vetoquinol S.A. Business Overview
11.9.3 Vetoquinol S.A. Veterinary Therapeutics Introduction
11.9.4 Vetoquinol S.A. Revenue in Veterinary Therapeutics Business (2016-2021)
11.9.5 Vetoquinol S.A. Recent Development
11.10 Zoetis, Inc.
11.10.1 Zoetis, Inc. Company Details
11.10.2 Zoetis, Inc. Business Overview
11.10.3 Zoetis, Inc. Veterinary Therapeutics Introduction
11.10.4 Zoetis, Inc. Revenue in Veterinary Therapeutics Business (2016-2021)
11.10.5 Zoetis, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Veterinary Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-inflammatory
Table 3. Key Players of Parasiticides
Table 4. Key Players of Others
Table 5. Global Veterinary Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Veterinary Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Veterinary Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Veterinary Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Veterinary Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Veterinary Therapeutics Market Share by Regions (2022-2027)
Table 11. Veterinary Therapeutics Market Trends
Table 12. Veterinary Therapeutics Market Drivers
Table 13. Veterinary Therapeutics Market Challenges
Table 14. Veterinary Therapeutics Market Restraints
Table 15. Global Veterinary Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Veterinary Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Veterinary Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Therapeutics as of 2020)
Table 18. Ranking of Global Top Veterinary Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Veterinary Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Veterinary Therapeutics Product Solution and Service
Table 22. Date of Enter into Veterinary Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Veterinary Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Veterinary Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Veterinary Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Veterinary Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Veterinary Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Veterinary Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Veterinary Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Veterinary Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Veterinary Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Veterinary Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Veterinary Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Veterinary Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Veterinary Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Veterinary Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Veterinary Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Veterinary Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Veterinary Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Veterinary Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Veterinary Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Veterinary Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Veterinary Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Veterinary Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Veterinary Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Veterinary Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Veterinary Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Veterinary Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Veterinary Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Veterinary Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Veterinary Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Veterinary Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Veterinary Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Veterinary Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Veterinary Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Veterinary Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Veterinary Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Veterinary Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Veterinary Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Veterinary Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bayer AG Company Details
Table 63. Bayer AG Business Overview
Table 64. Bayer AG Veterinary Therapeutics Product
Table 65. Bayer AG Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Bayer AG Recent Development
Table 67. Boehringer Ingelheim GmbH Company Details
Table 68. Boehringer Ingelheim GmbH Business Overview
Table 69. Boehringer Ingelheim GmbH Veterinary Therapeutics Product
Table 70. Boehringer Ingelheim GmbH Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Boehringer Ingelheim GmbH Recent Development
Table 72. Ceva Sante Animale Company Details
Table 73. Ceva Sante Animale Business Overview
Table 74. Ceva Sante Animale Veterinary Therapeutics Product
Table 75. Ceva Sante Animale Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Ceva Sante Animale Recent Development
Table 77. Dechra Pharmaceuticals PLC Company Details
Table 78. Dechra Pharmaceuticals PLC Business Overview
Table 79. Dechra Pharmaceuticals PLC Veterinary Therapeutics Product
Table 80. Dechra Pharmaceuticals PLC Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Dechra Pharmaceuticals PLC Recent Development
Table 82. Eli Lilly and Company (Elanco Animal Health) Company Details
Table 83. Eli Lilly and Company (Elanco Animal Health) Business Overview
Table 84. Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Product
Table 85. Eli Lilly and Company (Elanco Animal Health) Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Eli Lilly and Company (Elanco Animal Health) Recent Development
Table 87. Merck Animal Health Company Details
Table 88. Merck Animal Health Business Overview
Table 89. Merck Animal Health Veterinary Therapeutics Product
Table 90. Merck Animal Health Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Merck Animal Health Recent Development
Table 92. Sanofi (Merial Animal Health) Company Details
Table 93. Sanofi (Merial Animal Health) Business Overview
Table 94. Sanofi (Merial Animal Health) Veterinary Therapeutics Product
Table 95. Sanofi (Merial Animal Health) Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Sanofi (Merial Animal Health) Recent Development
Table 97. Virbac Company Details
Table 98. Virbac Business Overview
Table 99. Virbac Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Virbac Recent Development
Table 101. Vetoquinol S.A. Company Details
Table 102. Vetoquinol S.A. Business Overview
Table 103. Vetoquinol S.A. Veterinary Therapeutics Product
Table 104. Vetoquinol S.A. Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Vetoquinol S.A. Recent Development
Table 106. Zoetis, Inc. Company Details
Table 107. Zoetis, Inc. Business Overview
Table 108. Zoetis, Inc. Veterinary Therapeutics Product
Table 109. Zoetis, Inc. Revenue in Veterinary Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Zoetis, Inc. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Veterinary Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Anti-inflammatory Features
Figure 3. Parasiticides Features
Figure 4. Others Features
Figure 5. Global Veterinary Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Veterinary Clinics Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Others Case Studies
Figure 10. Veterinary Therapeutics Report Years Considered
Figure 11. Global Veterinary Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Veterinary Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Veterinary Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Veterinary Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Veterinary Therapeutics Market Share by Players in 2020
Figure 16. Global Top Veterinary Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Veterinary Therapeutics Revenue in 2020
Figure 18. Global Veterinary Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Veterinary Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Veterinary Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Veterinary Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Veterinary Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Veterinary Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Veterinary Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Veterinary Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Veterinary Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Veterinary Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Veterinary Therapeutics Market Share by Region (2016-2027)
Figure 40. China Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Veterinary Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Veterinary Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Veterinary Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Veterinary Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Veterinary Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Veterinary Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Veterinary Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bayer AG Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021)
Figure 60. Boehringer Ingelheim GmbH Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021)
Figure 61. Ceva Sante Animale Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021)
Figure 62. Dechra Pharmaceuticals PLC Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021)
Figure 63. Eli Lilly and Company (Elanco Animal Health) Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021)
Figure 64. Merck Animal Health Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021)
Figure 65. Sanofi (Merial Animal Health) Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021)
Figure 66. Virbac Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021)
Figure 67. Vetoquinol S.A. Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021)
Figure 68. Zoetis, Inc. Revenue Growth Rate in Veterinary Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs